Aikido provides update on use of machine learning in drug development program

New york, aug. 6, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today provided and update on the use of machine learning in support of its antiviral platform with the university of maryland baltimore school of medicine.  the company stated:  the goal for the project is the identification and optimization of anti-viral compounds that inhibit viral replication by targeting a protein complex that degrades rna at the cellular level.
DOMH Ratings Summary
DOMH Quant Ranking